Rayid Abdulqawi

P2X3 receptor antagonist (AF-219) in refractory chronic cough: a randomised, double-blind, placebo-controlled phase 2 study

Rayid Abdulqawi, Rachel Dockry, Kimberley Holt et al. · The Lancet · 2014 · 473 citations

Asthma, Placebo-controlled Phase 2, Pharmacology +6

Clinical characteristics of non-intensive care unit COVID-19 patients in Saudi Arabia: A descriptive cross-sectional study

Awad Al‐Omari, Waad N. Alhuqbani, Abdul Rehman Zia Zaidi et al. · Journal of Infection and Public Health · 2020 · 94 citations · Full text

Clinical, epidemiological, and laboratory characteristics of mild-to-moderate COVID-19 patients in Saudi Arabia: an observational cohort study

Abbas Al Mutair, Saad Alhumaid, Waad N. Alhuqbani et al. · European journal of medical research · 2020 · 81 citations · Full text

Assessing cough symptom severity in refractory or unexplained chronic cough: findings from patient focus groups and an international expert panel

Elena Kum, Gordon Guyatt, Caroline Munoz et al. · ERJ Open Research · 2022 · 26 citations · Full text

A Randomized Controlled Trial to Assess the Effect of Lidocaine Administered via Throat Spray and Nebulization in Patients with Refractory Chronic Cough

Rayid Abdulqawi, Imran Satia, Yoshihiro Kanemitsu et al. · The Journal of Allergy and Clinical Immunology In Practice · 2020 · 22 citations · Full text

Asthma, Throat Spray, Randomized Controlled Trial +4